AKT1 and injury: As a potential natural AKT inhibitor, SW could directly target the structural domain of AKT-PH to inhibit AKT activation and downregulate the phosphorylation level of AKT, which further inhibits the production of downstream inflammatory molecules, thus presenting significant anti-inflammatory activity in cells and animal models of acute lung injury [90].